Complications and revision rates after total shoulder arthroplasty are similar between patients with and without diabetes mellitus.

IF 1.5 Q3 ORTHOPEDICS

Shoulder and Elbow Pub Date : 2024-09-25 DOI:10.1177/17585732241278207

Ryan Sanii, Johnny Kasto, Joshua P Castle, Jordan Jay, Gabriel Burdick, Stephanie J Muh

{"title":"Complications and revision rates after total shoulder arthroplasty are similar between patients with and without diabetes mellitus.","authors":"Ryan Sanii, Johnny Kasto, Joshua P Castle, Jordan Jay, Gabriel Burdick, Stephanie J Muh","doi":"10.1177/17585732241278207","DOIUrl":null,"url":null,"abstract":"Purpose: There is wide variability in the conclusions of studies examining the effects of diabetes mellitus (DM) on outcomes of shoulder arthroplasty (SA). The objective of this study was to determine if there are differences in complication profiles between patients with DM and those without undergoing anatomic and reverse total SA.Methods: A retrospective review of patients undergoing SA in a single center from January 2014 to December 2019 was performed. Patients were then stratified into two cohorts, patients with controlled DM (mean hemoglobin A1C < 7%) and those without. Outcomes analyzed included intraoperative complications, postoperative complications, and revision surgery rates. Emergency department (ED) visits and hospital readmissions within 30 days were also recorded.Results: A total of 595 patients underwent SA. No significant difference was found between the diabetes (n = 151) and control group (n = 444) with regard to length of stay (P = .168), complications (P = .286), infection rate (P = .977), 30-day ED visits (P = .789), and readmissions (P = .230). The average time to revision was 26.8 months in the diabetes group and 26.6 months in the control group (P = .989).Conclusions: Following SA patients with controlled DM showed no increased risk of postoperative infection, ED visitation,hospital readmission, and revision surgery rate when compared to non-diabetics.Level of evidence: Level III-retrospective cohort.","PeriodicalId":36705,"journal":{"name":"Shoulder and Elbow","volume":" ","pages":"17585732241278207"},"PeriodicalIF":1.5000,"publicationDate":"2024-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559953/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Shoulder and Elbow","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/17585732241278207","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ORTHOPEDICS","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: There is wide variability in the conclusions of studies examining the effects of diabetes mellitus (DM) on outcomes of shoulder arthroplasty (SA). The objective of this study was to determine if there are differences in complication profiles between patients with DM and those without undergoing anatomic and reverse total SA.

Methods: A retrospective review of patients undergoing SA in a single center from January 2014 to December 2019 was performed. Patients were then stratified into two cohorts, patients with controlled DM (mean hemoglobin A1C < 7%) and those without. Outcomes analyzed included intraoperative complications, postoperative complications, and revision surgery rates. Emergency department (ED) visits and hospital readmissions within 30 days were also recorded.

Results: A total of 595 patients underwent SA. No significant difference was found between the diabetes (n = 151) and control group (n = 444) with regard to length of stay (P = .168), complications (P = .286), infection rate (P = .977), 30-day ED visits (P = .789), and readmissions (P = .230). The average time to revision was 26.8 months in the diabetes group and 26.6 months in the control group (P = .989).

Conclusions: Following SA patients with controlled DM showed no increased risk of postoperative infection, ED visitation,hospital readmission, and revision surgery rate when compared to non-diabetics.

Level of evidence: Level III-retrospective cohort.

查看原文本刊更多论文

糖尿病患者和非糖尿病患者接受全肩关节置换术后的并发症和翻修率相似。

目的：有关糖尿病（DM）对肩关节置换术（SA）结果影响的研究结论存在很大差异。本研究旨在确定接受解剖和反向全肩关节置换术的糖尿病患者与非糖尿病患者在并发症方面是否存在差异：方法：对2014年1月至2019年12月在一个中心接受SA手术的患者进行回顾性研究。然后将患者分为两个组群，即DM得到控制的患者（平均血红蛋白A1C结果）和DM未得到控制的患者（平均血红蛋白A1C结果）：共有 595 名患者接受了 SA 治疗。糖尿病组（n = 151）和对照组（n = 444）在住院时间（P = .168）、并发症（P = .286）、感染率（P = .977）、30 天急诊就诊率（P = .789）和再住院率（P = .230）方面无明显差异。糖尿病组的平均翻修时间为26.8个月，对照组为26.6个月（P = .989）：结论：与非糖尿病患者相比，糖尿病得到控制的SA患者在术后感染、急诊室就诊、再次入院和翻修手术率方面的风险没有增加：证据等级：III级--回顾性队列。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Shoulder and Elbow Medicine-Rehabilitation

CiteScore

2.80

自引率

0.00%

发文量